Orange Therapeutics is developing conversational virtual humans to deliver therapy - remotely, 24/7 - to patients of specific disorder populations. We are teaming with the Stanford University School of Medicine and the NYU Grossman School of Medicine as sub award institutions on the NIH STTR grant for which we're applying, and were 1 of 16 promising companies awarded an NIH-sponsored grants specialist by the NIA (National Institute for Aging) to help us execute a successful grant application.